Moreover, additional groups of tumor‐bearing mice received intraperitoneal CDDP (1 mg/kg) administration along with the vector at days 0, 4, 7, 11, and 14 post vector treatment in order to investigate the effects of combination of chemotherapy and TNFα gene therapy, chemovirotherapy. Here, TNF is linked to neoplasm.